@article{oai:repo.qst.go.jp:00084946,
 author = {Ono, Takashi and Yamamoto, Naoyoshi and Nomoto, Akihiro and Nakajima, Mio and Iwai, Yuma and Isozaki, Yuka and Kasuya, Goro and Ishikawa, Hitoshi and Nemoto, Kenji and Tsuji, Hiroshi and Takashi, Ono and Naoyoshi, Yamamoto and Akihiro, Nomoto and Mio, Nakajima and Yuma, Iwai and Yuka, Isozaki and Goro, Kasuya and Hitoshi, Ishikawa and Kenji, Nemoto and Hiroshi, Tsuji},
 issue = {13},
 journal = {Cancers},
 month = {Jun},
 note = {There are no studies on the risk factors of radiation pneumonitis (RP) after carbon-ion radiotherapy at a dose of 50 Gy (relative biological effectiveness (RBE)) in a single fraction. The objective of this study was to identify factors associated with RP after radiotherapy, including dose-volume parameters. Ninety-eight patients without a history of thoracic radiotherapy who underwent treatment for solitary lung tumors between July 2013 and April 2016 were retrospectively analyzed. Treatment was planned using Xio-N. The median follow-up duration was 53 months, and the median clinical target volume was 32.3 mL. Three patients developed grade 2 RP, and one patient developed grade 3 interstitial pneumonitis. None of the patients developed grade 4 or 5 RP. The dose-volume parameters of the normal lung irradiated at least with 5-30 Gy (RBE), and the mean lung dose was significantly lower in patients with grade 0-1 RP than in those with grade 2-3 RP. Pretreatment with higher SP-D and interstitial pneumonitis were significant factors for the occurrence of symptomatic RP. The present study showed a certain standard for single-fraction carbon-ion radiotherapy that does not increase the risk of RP; however, further validation studies are needed.},
 title = {The Risk Factors for Radiation Pneumonitis After Single-Fraction Carbon-Ion Radiotherapy for Lung Cancer or Metastasis.},
 volume = {13},
 year = {2021}
}